Patents Represented by Attorney Harriet M. Strimpel
-
Patent number: 8163529Abstract: A nicking endonuclease is described which has an amino acid sequence with at least 70% identity to SEQ ID NO:6 and comprising a mutation at least one of an arginine or glutamic acid corresponding to position 507 and position 546 respectively in SEQ ID NO:6.Type: GrantFiled: October 18, 2010Date of Patent: April 24, 2012Assignee: New England Biolabs, Inc.Inventors: Shuang-Yong Xu, Zhenyu Zhu, Timothy Meixsell
-
Patent number: 7943303Abstract: Methods are provided for engineering novel strand-specific nicking endonucleases by means of an in vivo enrichment of a plasmid library containing a randomly mutagenized restriction endonuclease gene. The plasmids contain adjacent to the gene a cleavable or nickable sequence for cleaving or nicking by the endonuclease product of the gene and a second recognition site for a second endonuclease. The plasmid library is used to transform unmodified host cells. Plasmids from the cultured transformed cells may be analyzed by an in vitro assay for nicking and the nicked plasmids pooled and used to transform host cells. The product is then pooled and the single-stranded specificity of the endonuclease is then determined. The product is either cloned after amplification or identified by use of a selectable marker.Type: GrantFiled: December 15, 2004Date of Patent: May 17, 2011Assignee: New England Biolabs, Inc.Inventors: Shuang-yong Xu, James Samuelson
-
Patent number: 7939284Abstract: A method using O6-alkylguanine-DNA alkyltransferases (AGT) is disclosed for transferring a label from a substrate to a fusion protein comprising the AGT. This allows the detection and/or manipulating of the fusion protein, both in vitro and in vivo, by attaching molecules to the fusion proteins that introduce a new physical or chemical property to the fusion protein. Examples of such molecules are, among others, spectroscopic probes or reporter molecules, affinity tags, molecules generating reactive radicals, cross-linkers, ligands mediating protein-protein interactions or molecules suitable for the immobilisation of the fusion protein.Type: GrantFiled: April 5, 2002Date of Patent: May 10, 2011Assignee: Ecole Polytechnique Federale de LausanneInventors: Kai Johnsson, Susanne Gendreizig, Antje Keppler
-
Patent number: 7935509Abstract: Methods and compositions are provided that relate to obtaining a recombinant DNA and RNA cleaving nuclease. This involves the over-expression of a fusion protein between maltose-binding protein and a truncated nuclease in a soluble form in the cytoplasm of a host cell from which it can be readily extracted.Type: GrantFiled: August 12, 2005Date of Patent: May 3, 2011Assignee: New England Biolabs, Inc.Inventor: Pei-Chung Hsieh
-
Patent number: 7888090Abstract: The invention relates to AGT mutants showing, when compared to the wild type human AGT, two or more advantageous properties selected from (a) reduced DNA interaction; (b) localisation of the expressed protein in eukaryotic cells that is no longer restricted to the nucleus; (c) improved expression yield as soluble protein and improved stability in various hosts; (d) improved stability under oxidising conditions; (e) improved stability within cells after reaction with a substrate; (f) improved stability outside cells before and after reaction with a substrate; (g) improved in vitro solubility; (h) improved reactivity against O6-alkylguanine substrates; (1) reduced reactivity against DNA-based substrates; and (j) reduced reactivity against N9-substituted O6-alkylguanine substrates.Type: GrantFiled: March 1, 2005Date of Patent: February 15, 2011Assignee: Ecole Polytechnique Federale de LausanneInventors: Jan Barnikow, Christopher Chidley, Thomas Gronemeyer, Christian Heinis, Hughes Jaccard, Kai Johnsson, Alexandre Juillerat, Antje Keppler
-
Patent number: 7883867Abstract: Methods and compositions are provided for increasing at least one of: (i) binding affinity of a target protein for a maltodextrin substrate and/or (ii) solubility of a target protein. The methods and compositions relate to a modified maltose-binding protein.Type: GrantFiled: August 16, 2010Date of Patent: February 8, 2011Assignee: New England Biolabs, Inc.Inventors: Paul Riggs, Pei-Chung Hsieh, Iris Walker, Paul A. Colussi, Mehul Ganatra, Christopher H. Taron
-
Patent number: 7851192Abstract: Compositions and methods are provided that relate to a modified DNA cleaving enzyme having at least 35% amino acid sequence identity with T7 Endo I. The modified enzyme includes two catalytic centers separated by a ?-bridge where the ?-bridge contains at least one mutation having an effect of altering enzyme cleavage activity compared to the unmodified enzyme. Activities associated with the modified DNA cleaving enzyme that can be modulated in different reaction conditions include at least one of: (a) non-sequence specific nicking activity; (b) cleaving the second strand of a duplex DNA at a preexisting nick site to produce a linear duplex with a single strand overhang; (c) non-sequence specific DNA cleavage; (d) cleaving DNA flanking a mismatch; and (e) cleavage at a cruciform structure in a DNA duplex.Type: GrantFiled: November 22, 2004Date of Patent: December 14, 2010Assignee: New England Biolabs, Inc.Inventors: Chudi Guan, Sanjay Kumar, Rebecca Kucera
-
Patent number: 7833769Abstract: Compositions and methods are provided in which the composition is a protein with at least 50% but less than 100% amino acid sequence identity with McrA or is a variant McrA protein with at least one amino acid sequence modification. The variant or protein has the property of cleaving DNA with methylated cytosine and not hydroxymethylated cytosine in a target DNA sequence, or substantially lacks catalytic activity while maintaining binding activity. Methods are provided in which the protein or McrA variant are used to identify methylation sites either by cleavage or by binding to the methylation site in the presence of a marker or by binding to an immobilized protein or McrA variant.Type: GrantFiled: April 27, 2005Date of Patent: November 16, 2010Assignee: New England Biolabs, Inc.Inventors: Brian P. Anton, Elisabeth A. Raleigh
-
Patent number: 7829284Abstract: Methods and a kit are provided for selectively and exponentially amplifying nucleic acids and include the use of a helicase preparation and a DNA polymerase such that the amplification can be performed isothermally.Type: GrantFiled: April 27, 2007Date of Patent: November 9, 2010Assignee: New England Biolabs, Inc.Inventors: Huimin Kong, Myriam Vincent, Yan Xu
-
Patent number: 7825218Abstract: Methods and compositions are provided for increasing at least one of: (i) binding affinity of a target protein for a maltodextrin substrate and/or (ii) solubility of a target protein. The methods and compositions relate to a modified maltose-binding protein.Type: GrantFiled: April 14, 2007Date of Patent: November 2, 2010Assignee: New England Biolabs, Inc.Inventors: Paul Riggs, Pei-Chung Hsieh, Iris Walker, Paul A. Colussi, Mehul Ganatra, Christopher H. Taron
-
Patent number: 7820424Abstract: A nicking endonuclease is described which has an amino acid sequence with at least 70% identity to SEQ ID NO:6 and comprising a mutation at least one of an arginine or glutamic acid corresponding to position 507 and position 546 respectively in SEQ ID NO:6.Type: GrantFiled: July 22, 2005Date of Patent: October 26, 2010Assignee: New England Biolabs, Inc.Inventors: Shuang-Yong Xu, Zhenyu Zhu, Timothy Meixsell
-
Patent number: 7799524Abstract: The invention relates to compounds of formula 1 wherein R1-R2 is a guanine derivative; X is oxygen or sulfur; R3 is a heteroaromatic, unsaturated heterocyclyl or an alkynyl group with the double or triple bond connected to CH2; R4 is a linker; and L is a label, a plurality of same or different labels, a bond connecting R4 to R1 forming a cyclic substrate, or a further group —R3—CH2—X—R1-R2. The invention relates also to methods of manufacture of such novel AGT substrates, to intermediates useful in the synthesis of such AGT substrates, and to a method of transferring a label from such AGT substrates to O6-alkylguanine-DNA alkyltransferase (AGT) fusion proteins comprising proteins of interest.Type: GrantFiled: October 1, 2003Date of Patent: September 21, 2010Assignee: Ecole Polytechnique Ferdeale de LausanneInventors: Maik Kindermann, Kai Johnsson, Christoph Bieri
-
Patent number: 7732565Abstract: Compositions and methods are provided for creating and identifying mutant carbohydrate-binding proteins that reversibly bind to carbohydrate substrates under conditions where the native protein remains bound. Examples of modified chitin-binding domains are provided which can be eluted from chitin in the presence of a reducing agent or at a pH within the range of 5-10.Type: GrantFiled: September 20, 2006Date of Patent: June 8, 2010Assignee: New England Biolabs, Inc.Inventors: Christopher H. Taron, Paul A. Colussi, Jeremiah Read
-
Patent number: 7700758Abstract: A method for obtaining a mixture of heterogenous short double-stranded RNA molecules suitable for use in gene silencing (hsiRNA) by subjecting large double-stranded RNA to enzymatic cleavage under specified conditions. The resulting mixture consistently includes enhanced representation of fragments having a size of 21-22 nucleotides absent any fractionation step. The fragments contain sequences that collectively span the entire length of the large double-stranded RNA from which they are derived. Double-stranded RNA with sequences that individually represent segments of a target mRNA may be analyzed using the methods described herein to identify the most active subset of hsiRNA fragments or individual siRNA fragments for achieving gene silencing for any gene or transcribed sequences. A method is additionally provided for preparing and cloning DNA encoding selected siRNA, hsiRNA mixtures or hairpin sequences to provide a continuous supply of a gene silencing reagent derived from any long double-stranded RNA.Type: GrantFiled: July 18, 2003Date of Patent: April 20, 2010Assignee: New England Biolabs, Inc.Inventors: George Tzertzinis, George Feehery, Christopher Noren, Corinna Tuckey, Larry McReynolds, Yinhua Zhang
-
Patent number: 7700283Abstract: Methods and compositions are provided for repairing a polynucleotide so that it can be synthesized efficiently with improved fidelity and yield in, for example, an amplification reaction. This involves the use of a reaction mixture that includes a ligase and a cofactor selected from NAD+ or ATP and incubating the polynucleotide with the reaction mixture in the absence of Endonuclease VI. The reaction mixture may further contain an AP endonuclease and a polymerase. These enzymes are optionally selected according to their ability to withstand high temperatures so they can be included in an amplification mixture. The reaction mixture may be used prior to a polynucleotide synthesis reaction in which case enzymes that are not thermophilic may be used. The repair reaction is not time sensitive with respect to seconds, minutes or hours of incubation in the enzyme mixture.Type: GrantFiled: October 20, 2005Date of Patent: April 20, 2010Assignee: New England Biolabs, Inc.Inventors: Thomas C. Evans, Barton Slatko, Lixin Chen, Romaldas Vaisvila, Chudi Guan
-
Patent number: 7695964Abstract: Compositions and methods are provided for preparing an hsiRNA mixture and for silencing of gene expression in vivo. The composition relates to a mutant RnaseIII. The methods are directed to reacting a preparation of dsRNA with an effective amount of a mutant RNAse III to produce the hsiRNA mixture.Type: GrantFiled: January 21, 2005Date of Patent: April 13, 2010Assignee: New England Biolabs, Inc.Inventors: Claude V. Maina, George Tzertzinis, Sanjay Kumar
-
Patent number: 7662594Abstract: Methods and a kit are provided for selectively and exponentially amplifying nucleic acids and include the use of a single strand helicase preparation or a thermostable helicase in the absence of a single strand binding protein and a DNA polymerase such that the amplification can be performed isothermally.Type: GrantFiled: January 5, 2006Date of Patent: February 16, 2010Assignee: New England Biolabs, Inc.Inventors: Huimin Kong, Myriam Vincent, Yan Xu
-
Patent number: 7435572Abstract: Methods and compositions are provided for generating a single-stranded extension on a polynucleotide molecule, the single-stranded extension having a desired length and sequence composition. Methods for forming single-stranded extensions include: the use of a cassette containing at least one nicking site and at least one restriction site at a predetermined distance from each other and in a predetermined orientation; or primer-dependent amplification which introduces into a polynucleotide molecule, a modified nucleotide which is excised to create a nick using a nicking agent. The methods and compositions provided can be used to manipulate a DNA sequence including introducing site specific mutations into a polynucleotide molecule and for cloning any polynucleotide molecule or set of joined polynucleotide molecules in a recipient molecule such as a vector of choice.Type: GrantFiled: April 4, 2003Date of Patent: October 14, 2008Assignee: New England Biolabs, Inc.Inventor: Jurate Bitinaite
-
Patent number: 7390636Abstract: Methods and compositions are provided relating to production of recombinant protein in yeast. A modified PLAC4 is described where one or more mutations may be introduced into the Pribnow box-like sequences in the promoter. The modified promoter when placed upstream of a target gene in a vector causes a significant reduction of target gene expression in transformed bacteria but produces efficient expression of the target gene in yeast.Type: GrantFiled: April 8, 2005Date of Patent: June 24, 2008Assignee: New England Biolabs, Inc.Inventors: Christopher Taron, Paul Colussi
-
Patent number: 7319014Abstract: Compositions for an alkaline phosphatase and methods for over-expression and purification of thermolabile Antarctic phosphatase (TAP) are provided. Uses for TAP include dephosphorylation of nucleic acids, sugars, peptides and proteins. TAP as described herein has advantages over phosphatases from other sources with respect to thermolability at 65° C. and efficiency of dephosphorylation activity at approximately neutral pH.Type: GrantFiled: February 20, 2004Date of Patent: January 15, 2008Assignee: New England Biolabs, Inc.Inventors: Ellen Guthrie, Theodore Davis, Jack Benner, II